CH436302A - Verfahren zur Herstellung 6-basisch substituierter Morphanthridine - Google Patents
Verfahren zur Herstellung 6-basisch substituierter MorphanthridineInfo
- Publication number
- CH436302A CH436302A CH741363A CH741363A CH436302A CH 436302 A CH436302 A CH 436302A CH 741363 A CH741363 A CH 741363A CH 741363 A CH741363 A CH 741363A CH 436302 A CH436302 A CH 436302A
- Authority
- CH
- Switzerland
- Prior art keywords
- sep
- formula
- acid
- preparation
- hydrogen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 150000003951 lactams Chemical class 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PWRPUAKXMQAFCJ-UHFFFAOYSA-N Perlapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2CC2=CC=CC=C12 PWRPUAKXMQAFCJ-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 2
- 229960001076 chlorpromazine Drugs 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- DHSLOIFKVQGCQU-UHFFFAOYSA-N n-(10h-anthracen-9-ylidene)hydroxylamine Chemical class C1=CC=C2C(=NO)C3=CC=CC=C3CC2=C1 DHSLOIFKVQGCQU-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- -1 4-methyl-1-piperazinyl group Chemical group 0.000 description 1
- ANVUIQDFTNLNMQ-UHFFFAOYSA-N 8-chloro-6-(4-methylpiperazin-1-yl)-11h-benzo[c][1]benzazepine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2CC2=CC=C(Cl)C=C12 ANVUIQDFTNLNMQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000006237 Beckmann rearrangement reaction Methods 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 238000006434 Ritter amidation reaction Methods 0.000 description 1
- 238000006085 Schmidt reaction Methods 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- UEDBHEFYEKZZBA-UHFFFAOYSA-N ac1np5zy Chemical compound C1=CC=[C+]=C[CH]1 UEDBHEFYEKZZBA-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical class C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 150000008425 anthrones Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000002560 nitrile group Chemical group 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003571 thiolactams Chemical class 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/238—Cyclohexane rings substituted by two guanidine radicals, e.g. streptomycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH741363A CH436302A (de) | 1963-06-14 | 1963-06-14 | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine |
| AT87765A AT248449B (de) | 1963-06-14 | 1964-02-03 | Verfahren zur Herstellung von neuen, in 6-Stellung basisch substituierten Morphanthridinen |
| GB22367/64A GB1006156A (en) | 1963-06-14 | 1964-05-29 | 6-basic substituted morphanthridines |
| AT475064A AT246167B (de) | 1963-06-14 | 1964-06-02 | Verfahren zur Herstellung von neuen, in 6-Stellung basisch substituierten Morphanthridinen |
| AT87565A AT247360B (de) | 1963-06-14 | 1964-06-02 | Verfahren zur Herstellung von neuen, in 6-Stellung basisch substituierten Morphanthridinen |
| AT87665A AT248448B (de) | 1963-06-14 | 1964-06-02 | Verfahren zur Herstellung von neuen, in 6-Stellung basisch substituierten Morphanthridinen |
| DE19641470427 DE1470427C3 (de) | 1963-06-14 | 1964-06-02 | Substituierte 6-Piperazino-morphanthridine |
| NO15363064A NO115658B (da) | 1963-06-14 | 1964-06-11 | |
| NL646406700A NL140239B (nl) | 1963-06-14 | 1964-06-12 | Werkwijze ter bereiding van op de 6-plaats gesubstitueerde morfantridinen, alsmede werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. |
| DK86865A DK107616C (da) | 1963-06-14 | 1964-06-12 | Fremgangsmåde til fremstilling af i 6-stillingen basisk substiturede morphanthridiner eller syreadditionssalte deraf. |
| FR978010A FR3490M (fr) | 1963-06-14 | 1964-06-12 | Morphanthridines substituées par des groupes basiques en position 6, utiles comme agents neuroplégiques, neuroleptiques et analgésiques. |
| DK296164A DK107612C (da) | 1963-06-14 | 1964-06-12 | Fremgangsmåde til fremstilling af i 6-stillingen basisk substituerede morphanthridiner eller syreadditionssalte deraf. |
| SE718864A SE318279B (da) | 1963-06-14 | 1964-06-12 | |
| SE1631665A SE331683B (da) | 1963-06-14 | 1964-06-12 | |
| FI128164A FI42561B (da) | 1963-06-14 | 1964-06-12 | |
| DK86765A DK107615C (da) | 1963-06-14 | 1964-06-12 | Fremgangsmåde til fremstilling af i 6-stillingen basisk substituerede morphanthridiner eller syreadditionssalte deraf. |
| SE1631765A SE331684B (da) | 1963-06-14 | 1964-06-12 | |
| BR15998664A BR6459986D0 (pt) | 1963-06-14 | 1964-06-12 | Processo para a preparacao de morfantridinas basicamente substituidas em posicao 6 |
| ES300986A ES300986A1 (es) | 1963-06-14 | 1964-06-13 | Procedimiento para la preparación de morfantridinas 6 - básicamente sustituídas |
| BE649284A BE649284A (da) | 1963-06-14 | 1964-06-15 | |
| DK86965A DK115402B (da) | 1963-06-14 | 1965-02-19 | Fremgangsmåde til fremstilling af i 6-stillingen basisk substituerede morphanthridiner eller syradditionssalte deraf. |
| SE1631865A SE331685B (da) | 1963-06-14 | 1965-06-12 | |
| US554670A US3389139A (en) | 1963-06-14 | 1966-06-02 | 6-homopiperazino and piperazinomorphanthridines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH741363A CH436302A (de) | 1963-06-14 | 1963-06-14 | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH436302A true CH436302A (de) | 1967-05-31 |
Family
ID=4324732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH741363A CH436302A (de) | 1963-06-14 | 1963-06-14 | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine |
Country Status (4)
| Country | Link |
|---|---|
| AT (4) | AT248449B (da) |
| CH (1) | CH436302A (da) |
| DK (3) | DK107612C (da) |
| ES (1) | ES300986A1 (da) |
-
1963
- 1963-06-14 CH CH741363A patent/CH436302A/de unknown
-
1964
- 1964-02-03 AT AT87765A patent/AT248449B/de active
- 1964-06-02 AT AT87665A patent/AT248448B/de active
- 1964-06-02 AT AT475064A patent/AT246167B/de active
- 1964-06-02 AT AT87565A patent/AT247360B/de active
- 1964-06-12 DK DK296164A patent/DK107612C/da active
- 1964-06-12 DK DK86865A patent/DK107616C/da active
- 1964-06-12 DK DK86765A patent/DK107615C/da active
- 1964-06-13 ES ES300986A patent/ES300986A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK107616C (da) | 1967-06-19 |
| AT248449B (de) | 1966-07-25 |
| ES300986A1 (es) | 1964-09-16 |
| AT246167B (de) | 1966-04-12 |
| AT248448B (de) | 1966-07-25 |
| DK107615C (da) | 1967-06-19 |
| AT247360B (de) | 1966-06-10 |
| DK107612C (da) | 1967-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2265371C3 (de) | N-(3-Benzoylaminopropyl)-aniline | |
| DE1670849B2 (de) | Verfahren zur herstellung von 8-acylamino-1,2,3,4-tetrahydroisochinolinen | |
| CH422793A (de) | Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine | |
| DE1470427C3 (de) | Substituierte 6-Piperazino-morphanthridine | |
| CH436306A (de) | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine | |
| CH476753A (de) | Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine | |
| CH436307A (de) | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine | |
| CH436305A (de) | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine | |
| CH450422A (de) | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine | |
| DE2600202C2 (de) | Verfahren zur Herstellung von Benzodiazepinen | |
| DE1038047B (de) | Verfahren zur Herstellung von N-aminoalkylierten Iminodibenzylen und deren Salzen | |
| CH502354A (de) | Verfahren zur Herstellung von Benzodiazepin-Derivaten | |
| DE1670162C3 (de) | Verfahren zur Herstellung von 2-substituierten Phenylamino-13-diazacycloalkenen-(2) und dessen Säureadditionssalzen | |
| AT349474B (de) | Verfahren zur herstellung von neuen, basisch substituierten 3,4-dihydro-2h-isochinolin-1- thionen und ihren salzen | |
| CH436308A (de) | Verfahren zur Herstellung 6-basisch substituierter Morphanthridine | |
| AT256825B (de) | Verfahren zur Herstellung von neuen heterocyclischen Benzamidoverbindungen und ihren Salzen | |
| DE1811831C3 (de) | Verfahren zur Herstellung von 5-Phenyl-13-dihydro-2H-l,4-benzodiazepin-2-on-derivaten | |
| AT246153B (de) | Verfahren zur Herstellung von neuen Triazinverbindungen | |
| AT311371B (de) | Verfahren zur Herstellung von neuen Pyridazon-6-iminen | |
| AT378960B (de) | Verfahren zur herstelllung von neuen imidazo (1,5-a) (1,4)diazepinverbindungen, ihren salzen und optisch aktiven formen | |
| CH450426A (de) | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine | |
| AT242132B (de) | Verfahren zur Herstellung von neuen Succinimidderivaten | |
| AT243445B (de) | Verfahren zur Herstellung von neuen, am Stickstoff substituierten 3-(Dibenzo-[a,d]-1, 4-cycloheptadien-5-yloxy)-nortropanen und von Salzen dieser Verbindungen | |
| AT251588B (de) | Verfahren zur Herstellung von Chinazolin-Derivaten | |
| CH450424A (de) | Verfahren zur Herstellung 11-basisch substituierter Dibenz(b,f)(1,4)oxazepine |